➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Last Updated: July 3, 2020

DrugPatentWatch Database Preview

Details for Biologics License Application: 021810

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Summary for BLA: 021810

Tradename:	NOVOLOG MIX 50/50
Applicant:	Novo Nordisk Inc
Ingredient:	insulin aspart protamine recombinant; insulin aspart recombinant
Patents:	10
Approval Date:	Nov 21, 2017

US Patents for BLA: 021810

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Novo Nordisk Inc	NOVOLOG MIX 50/50	insulin aspart protamine recombinant; insulin aspart recombinant	INJECTABLE;SUBCUTANEOUS	021810	001	2017-11-21	Start Trial	Novo Nordisk A/S (Basgsvaerd, DK)	2013-08-20	DISCN		company
Novo Nordisk Inc	NOVOLOG MIX 50/50	insulin aspart protamine recombinant; insulin aspart recombinant	INJECTABLE;SUBCUTANEOUS	021810	001	2017-11-21	Start Trial	Novo Nordisk A/S (Bagsvaerd, DK)	2014-04-08	DISCN		company
Novo Nordisk Inc	NOVOLOG MIX 50/50	insulin aspart protamine recombinant; insulin aspart recombinant	INJECTABLE;SUBCUTANEOUS	021810	001	2017-11-21	Start Trial	Novo Nordisk A/S (Bagsvaerd, DK)	2014-12-02	DISCN		company
Novo Nordisk Inc	NOVOLOG MIX 50/50	insulin aspart protamine recombinant; insulin aspart recombinant	INJECTABLE;SUBCUTANEOUS	021810	001	2017-11-21	Start Trial	Novo Nordisk A/S (Bagsvaerd, DK)	2013-06-21	DISCN		company
Novo Nordisk Inc	NOVOLOG MIX 50/50	insulin aspart protamine recombinant; insulin aspart recombinant	INJECTABLE;SUBCUTANEOUS	021810	001	2017-11-21	Start Trial	Novo Nordisk A/S (Bagsvaerd, DK)	2013-06-21	DISCN		company
Novo Nordisk Inc	NOVOLOG MIX 50/50	insulin aspart protamine recombinant; insulin aspart recombinant	INJECTABLE;SUBCUTANEOUS	021810	001	2017-11-21	Start Trial	Novo Nordisk A/S (Bagsvaerd, DK)	2016-06-20	DISCN		company
Novo Nordisk Inc	NOVOLOG MIX 50/50	insulin aspart protamine recombinant; insulin aspart recombinant	INJECTABLE;SUBCUTANEOUS	021810	001	2017-11-21	Start Trial	Novo Nordisk A/S (Bagsvaerd, DK)	2018-01-30	DISCN		company
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca

Colorcon

Moodys

Merck

Johnson and Johnson

Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.